FDA Advisory Panel Recommends Reclassification of Popular Peptides Amid Growing Wellness Demand and Regulatory Debate
In a decision that could significantly alter the landscape of the American wellness and longevity industry, a key advisory committee to the Food and Drug Administration (FDA) has narrowly recommended…
